American Portfolios Advisors Arrowhead Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 32,022 shares of ARWR stock, worth $674,063. This represents 0.04% of its overall portfolio holdings.

Number of Shares

32,022

Holding current value

$674,063

% of portfolio

0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$29.63 - $48.31 $948,811 - $1.55 Million	32,022 New	32,022 $1.06 Billion
Q2 2022 Mar 20, 2023	BUY	$27.79 - $50.61 $7,725 - $14,069	278 Added 0.87%	32,300 $1.14 Billion
Q1 2022 Mar 21, 2023	SELL	$39.62 - $69.97 $2,456 - $4,338	-62 Reduced 0.19%	31,960 $1.47 Billion
Q4 2021 Mar 21, 2023	SELL	$58.09 - $82.51 $213,713 - $303,554	-3,679 Reduced 11.49%	28,343 $1.88 Billion
Q3 2021 Mar 22, 2023	SELL	$58.38 - $84.96 $211,277 - $307,470	-3,619 Reduced 11.3%	28,403 $1.77 Billion
Q2 2021 Mar 22, 2023	SELL	$62.15 - $90.32 $245,119 - $356,222	-3,944 Reduced 12.32%	28,078 $2.33 Billion
Q1 2021 Mar 22, 2023	SELL	$61.35 - $90.47 $274,479 - $404,762	-4,474 Reduced 13.97%	27,548 $1.83 Billion
Q4 2020 Mar 22, 2023	SELL	$43.82 - $85.37 $188,382 - $367,005	-4,299 Reduced 13.43%	27,723 $2.13 Billion
Q3 2020 Mar 22, 2023	SELL	$33.21 - $51.27 $136,791 - $211,181	-4,119 Reduced 12.86%	27,903 $1.2 Billion
Q2 2020 Mar 24, 2023	BUY	$26.12 - $43.27 $13,399 - $22,197	513 Added 1.87%	27,956 $1.21 Billion
Q1 2020 Mar 24, 2023	SELL	$20.56 - $63.12 $94,144 - $289,026	-4,579 Reduced 14.3%	27,443 $790 Million
Q4 2019 Mar 24, 2023	SELL	$28.14 - $73.01 $154,263 - $400,240	-5,482 Reduced 17.12%	26,540 $1.68 Billion
Q3 2019 Mar 24, 2023	BUY	$26.26 - $34.86 $89,809 - $119,221	3,420 Added 20.79%	19,870 $560 Million
Q2 2019 Mar 24, 2023	SELL	$17.43 - $28.82 $271,419 - $448,785	-15,572 Reduced 48.63%	16,450 $436 Million
Q1 2019 Mar 24, 2023	BUY	$12.05 - $20.18 $28,920 - $48,432	2,400 Added 41.74%	8,150 $150 Million
Q4 2018 Mar 24, 2023	BUY	$10.74 - $19.7 $2,685 - $4,925	250 Added 4.55%	5,750 $71.4 Million
Q3 2018 Mar 24, 2023	SELL	$14.0 - $20.3 $371,308 - $538,396	-26,522 Reduced 82.82%	5,500 $105 Million
Q2 2018 Mar 24, 2023	BUY	$6.37 - $14.02 $22,295 - $49,070	3,500 Added 175.0%	5,500 $74.8 Million
Q1 2018 Mar 24, 2023	SELL	$3.72 - $7.64 $111,681 - $229,368	-30,022 Reduced 93.75%	2,000 $14.4 Million
Q4 2017 Mar 24, 2023	SELL	$3.14 - $4.5 $97,409 - $139,599	-31,022	1,000 $3.68 Million

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Arrowhead Pharmaceuticals, Inc. Transaction History